Home > Insider Trading > Filing (0001209191-13-006775)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
831547	Spectrum Pharmaceuticals Inc	SPPI	Pharmaceutical Preparations (2834)	930979187

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1273213	Iii E Anthony Maida	11500 S. Eastern Ave. Suite 240 Henderson NV 89052		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.001 Par Value	Acquisiton	2013-02-05	3,300	$4.26	5,550	No	4	M	Direct
Common Stock, $0.001 Par Value	Disposition	2013-02-05	3,300	$12.25	2,250	No	4	S	Direct
Common Stock, $0.001 Par Value	Acquisiton	2013-02-05	1,700	$3.92	3,950	No	4	M	Direct
Common Stock, $0.001 Par Value	Disposition	2013-02-05	1,700	$12.25	2,250	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option Exercise (Right to Buy)	Disposition	2013-02-05	3,300	$0.00	3,300	$4.26
Common Stock	Stock Option Exercise (Right to Buy)	Disposition	2013-02-05	1,700	$0.00	1,700	$3.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-01-01	2015-12-06	No	4	M	Direct
28,300		2020-07-01	No	4	M	Direct

Footnotes

All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2012.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.20 to $12.30, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The stock option, representing the right to purchase a total of 15,000 shares of common stock, was granted on December 6, 2005. The stock option became exercisable as to 3,750 shares on January 1, 2006, 3,750 shares on January 1, 2007, 3,750 shares on January 1, 2008, and 3,750 shares on January 1, 2009.
The stock option, representing the right to purchase a total of 30,000 shares of common stock, was granted on July 1, 2010. The stock option became exercisable as to 7,500 shares on July 1, 2010, 7,500 shares on July 1, 2011 and 7,500 shares on July 1, 2012. 7,500 shares will become exercisable on July 1, 2013.